Source avec lien : Journal of Oncology Pharmacy Practice, (En ligne). 10.1177/10781552231156520
Le personnel soignant est exposé à des médicaments dangereux tels que les médicaments antinéoplasiques, qui peuvent avoir des effets cancérigènes, mutagènes et tératogènes. Des mesures de protection doivent être prises après une formation appropriée du personnel pour manipuler les médicaments antinéoplasiques en toute sécurité. L’objectif était d’évaluer la perception, les connaissances, les pratiques et la formation concernant le risque d’exposition du personnel soignant dans trois unités de préparation française.
IntroductionHealthcare workers are exposed to hazardous drugs such as antineoplastic drugs, which have potential carcinogenic, mutagenic and teratogenic effects. Protective measures must be taken after appropriate staff training to handle antineoplastic drugs in a safe way. The objective was to assess perception, knowledge, practices and training regarding the risk of exposure of healthcare workers in three French compounding units.MethodsThis descriptive study was based on a questionnaire made of 33 questions divided into five sections related to the handling of antineoplastic drugs: perception of the risks, knowledge of the risks, protection practices, specific training and general questions.ResultsAmong the 39 participants, over half considered their overall risk of exposure to antineoplastic drugs not being very low. Inhalation was known to 69.2% of them as possible route of contamination. The breakroom was identified by 28.9% of them as a place of contamination. The procedure in case of accidental exposure to antineoplastic drugs was known by 69.2%, but only half could explain it. Only 38.5% said they changed their gloves every 30?min as recommended. Barely half said that they had been trained specifically for the handling of antineoplastic drugs during an initial training. Over half wished to be informed, trained and aware of the proper handling of antineoplastic drugs.ConclusionAlthough some of these results are encouraging, specifically when compared to the other settings where antineoplastic drugs are handled, there is still room for improvement. Efforts to build an adapted and impactful training program must pursue.Clinical trial registrationStudy CONTACT, ref. 19-504.